Beyond Medical Technologies Stock Filter Stocks by Fundamentals
| DOCKF Stock | USD 0.28 0.00 0.00% |
Fundamental analysis of Beyond Medical allows traders to better anticipate movements in Beyond Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
Beyond | Shares Owned by Insiders | Build AI portfolio with Beyond Stock |
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
| All Next | Launch Module |
Beyond Fundamentals
| Return On Equity | -1.89 | ||||
| Return On Asset | -1.35 | ||||
| Current Valuation | 16.84 M | ||||
| Shares Outstanding | 32.49 M | ||||
| Shares Owned By Insiders | 23.88 % | ||||
| Price To Earning | 38.84 X | ||||
| Price To Book | 98.35 X | ||||
| Price To Sales | 1.41 X | ||||
| Gross Profit | (250.49 K) | ||||
| EBITDA | (773.19 K) | ||||
| Net Income | (285.94 K) | ||||
| Cash And Equivalents | 877.31 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 60 K | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 3.73 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (109.77 K) | ||||
| Earnings Per Share | 0.01 X | ||||
| Target Price | 27.98 | ||||
| Beta | 7654.87 | ||||
| Market Capitalization | 16.81 M | ||||
| Total Asset | 13.8 K | ||||
| Retained Earnings | (26.38 M) | ||||
| Working Capital | (620.66 K) | ||||
| Net Asset | 13.8 K |
About Beyond Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beyond Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beyond Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beyond Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:Check out Beyond Medical Piotroski F Score and Beyond Medical Altman Z Score analysis. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth (0.92) | Return On Assets | Return On Equity |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.